title: Rapid decrease of free vancomycin in dense staphylococcal cultures.
abstract: Bacterial numbers in broth cultures were determined by bioluminescence assay of intracellular bacterial ATP. Broth MICs for strains of Staphylococcus epidermidis (ATCC 14990 and 35984) and Staphylococcus aureus (ATCC 25923, 29213 and 6538) were determined for cultures with different inocula (10(5)-10(8) bacteria/ml) after 24 h of incubation in supplemented Mueller-Hinton broth containing vancomycin. All of the tested strains except one were susceptible to methicillin, and all of the strains were susceptible to vancomycin. Free vancomycin concentrations in the broth cultures of all strains were determined with an agar well bioassay after 24 h of incubation. Free vancomycin concentrations and bacterial numbers of ATCC 35984 and ATCC 29213 were also determined after 0.5, 2, 4, and 8 h. In a low inoculum (10(5) bacteria/ml), the broth MICs were 1-4 microg/ml. In a high inoculum (approximately 10(8) bacteria/ml), the broth MICs increased two- to fourfold to 4-8 microg/ml. In dense inocula ( approximately 10(9)-10(10) bacteria/ml), the concentrations of free vancomycin in the broth were reduced, in most cases below the detection limit of the bioassay (</=0.5 microg/ml). This reduction of free vancomycin was fast, occurring in initially dense inocula in less than 30 min. No emergence of resistance was seen. These results show a rapid reduction of free vancomycin in the broth and a simultaneous increase in broth MICs in high inocula, without development of resistance. This indicates that the dosing regimen of vancomycin is of particular importance in staphylococcal infections with dense inocula, e.g. infective endocarditis.
authors.affiliation: Division of Infectious Diseases, Department of Molecular and Clinical Medicine, Faculty of Health Sciences, University of Linköping, 581 85, Linköping, Sweden. Christer.Ekdahl@lio.se
authors.forename: C
authors.initials: C
authors.lastname: Ekdahl
authors.forename: H
authors.initials: H
authors.lastname: Hanberger
authors.forename: A
authors.initials: A
authors.lastname: Hällgren
authors.forename: M
authors.initials: M
authors.lastname: Nilsson
authors.forename: E
authors.initials: E
authors.lastname: Svensson
authors.forename: L E
authors.initials: LE
authors.lastname: Nilsson
mesh_terms: D000255:Adenosine Triphosphate / Q000378:metabolism; D000900:Anti-Bacterial Agents / Q000378:metabolism / Q000494:pharmacology; D015169:Colony Count, Microbial; D006801:Humans; D066298:In Vitro Techniques; D049449:Luminescence; D013203:Staphylococcal Infections / Q000188:drug therapy; D013211:Staphylococcus aureus / Q000187:drug effects / Q000378:metabolism*; D013212:Staphylococcus epidermidis / Q000187:drug effects / Q000378:metabolism*; D014640:Vancomycin / Q000378:metabolism* / Q000494:pharmacology; D020713:Vancomycin Resistance
chemical_list: D000900:Anti-Bacterial Agents; D014640:Vancomycin; D000255:Adenosine Triphosphate